Literature DB >> 33276592

Progress in Research on Bioactive Secondary Metabolites from Deep-Sea Derived Microorganisms.

Ya-Nan Wang1,2,3, Ling-Hong Meng1,2, Bin-Gui Wang1,2,4.   

Abstract

Deep sea has an extreme environment which leads to biodiversity of microorganisms and their unique physical and biochemical mechanisms. Deep-sea derived microorganisms are more likely to produce novel bioactive substances with special mechanism of action for drug discovery. This article reviews secondary metabolites with biological activities such as anti-tumor, anti-bacterial, anti-viral, and anti-inflammatory isolated from deep-sea fungi and bacteria during 2018-2020. Effective methods for screening and obtaining natural active compounds from deep-sea microorganisms are also summarized, including optimizing the culture conditions, using genome mining technology, biosynthesis and so on. The comprehensive application of these methods makes broader prospects for the development and application of deep sea microbial bioactive substances.

Entities:  

Keywords:  bioactivity; deep-sea actinomycetes; deep-sea fungi; secondary metabolites

Year:  2020        PMID: 33276592     DOI: 10.3390/md18120614

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


  9 in total

1.  Antagonistic activity and mode of action of trypacidin from marine-derived Aspergillus fumigatus against Vibrio parahaemolyticus.

Authors:  Siya Guo; Zongyi Zhang; Xiaowen Xu; Jing Cai; Wenbin Wang; Lei Guo
Journal:  3 Biotech       Date:  2022-05-20       Impact factor: 2.893

2.  Isolation and Characterization of Strain Exiguobacterium sp. KRL4, a Producer of Bioactive Secondary Metabolites from a Tibetan Glacier.

Authors:  Pietro Tedesco; Fortunato Palma Esposito; Antonio Masino; Giovanni Andrea Vitale; Emiliana Tortorella; Annarita Poli; Barbara Nicolaus; Leonardo Joaquim van Zyl; Marla Trindade; Donatella de Pascale
Journal:  Microorganisms       Date:  2021-04-21

3.  Cytotoxic Minor Piericidin Derivatives from the Actinomycete Strain Streptomyces psammoticus SCSIO NS126.

Authors:  Kunlong Li; Ziqi Su; Yongli Gao; Xiuping Lin; Xiaoyan Pang; Bin Yang; Huaming Tao; Xiaowei Luo; Yonghong Liu; Xuefeng Zhou
Journal:  Mar Drugs       Date:  2021-07-28       Impact factor: 5.118

Review 4.  Research Progress in Anti-Inflammatory Bioactive Substances Derived from Marine Microorganisms, Sponges, Algae, and Corals.

Authors:  Chao-Qun Li; Qin-Yuan Ma; Xiu-Zhen Gao; Xuan Wang; Bei-Li Zhang
Journal:  Mar Drugs       Date:  2021-10-14       Impact factor: 5.118

5.  Complete Genome Sequence of Two Deep-Sea Streptomyces Isolates from Madeira Archipelago and Evaluation of Their Biosynthetic Potential.

Authors:  Pedro Albuquerque; Inês Ribeiro; Sofia Correia; Ana Paula Mucha; Paula Tamagnini; Andreia Braga-Henriques; Maria de Fátima Carvalho; Marta V Mendes
Journal:  Mar Drugs       Date:  2021-11-01       Impact factor: 5.118

6.  Pro-angiogenic New Chloro-Azaphilone Derivatives From the Hadal Trench-Derived Fungus Chaetomium globosum YP-106.

Authors:  Yaqin Fan; Chunjiao Jiang; Yan Zhang; Zhiheng Ma; Peihai Li; Lizhong Guo; Ting Feng; Liman Zhou; Lili Xu
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

7.  Investigation on Metabolites in Structural Diversity from the Deep-Sea Sediment-Derived Bacterium Agrococcus sp. SCSIO 52902 and Their Biosynthesis.

Authors:  Wenping Ding; Yanqun Li; Xinpeng Tian; Min Chen; Zhihui Xiao; Rouwen Chen; Hao Yin; Si Zhang
Journal:  Mar Drugs       Date:  2022-06-29       Impact factor: 6.085

8.  High hydrostatic pressure shapes the development and production of secondary metabolites of Mariana Trench sediment fungi.

Authors:  Qingqing Peng; Yongqi Li; Ludan Deng; Jiasong Fang; Xi Yu
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

9.  Structure of the Cell-Wall-Associated Polysaccharides from the Deep-Sea Marine Bacterium Devosia submarina KMM 9415T.

Authors:  Maxim S Kokoulin; Lyudmila A Romanenko; Aleksandra S Kuzmich; Oleg Chernikov
Journal:  Mar Drugs       Date:  2021-11-26       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.